Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03035409 · ClinicalTrials.gov registry record · Phase 2
Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors
A Phase 2 study of Weight Loss and Advanced Malignant Solid Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Phase 2
- Development phase
- 129
- Enrollment target
- 1
- Study location
NCT03035409 is a Phase 2 study of Weight Loss and Advanced Malignant Solid Neoplasm that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 129 participants, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03035409, a Phase 2 study of Weight Loss and Advanced Malignant Solid Neoplasm, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 129 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase II trial studies how well anamorelin hydrochloride, physical activity, and nutritional counseling work in decreasing cancer-related fatigue in patients with incurable solid tumors that have spread to other parts of the body or have come back. Anamorelin hydrochloride, physical activity, and nutritional counseling may help to decrease cancer-related fatigue in patients with solid tumors.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Laboratory Biomarker Analysis
- BEHAVIORAL Exercise Intervention
- OTHER Nutritional Assessment
- DRUG Anamorelin Hydrochloride
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2017-02-08 |
| Est. Completion | 2026-02-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03035409
The ClinicalTrials.gov registry entry for NCT03035409 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (91% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Weight Loss appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT03035409 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03035409 about?
NCT03035409 is a clinical study titled "Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors". This phase II trial studies how well anamorelin hydrochloride, physical activity, and nutritional counseling work in decreasing cancer-related fatigue in patients with incurable solid tumors that have spread to other parts of the body or have come back. Anamorelin hydrochloride, physical activity, a...
What is the current status of trial NCT03035409?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 129 participants. The study started on 2017-02-08. Estimated completion is 2026-02-28.
What conditions does trial NCT03035409 study?
This clinical trial studies the following conditions: Weight Loss, Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm, Cancer Fatigue.
What interventions are being tested in trial NCT03035409?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Laboratory Biomarker Analysis (OTHER), Exercise Intervention (BEHAVIORAL), Nutritional Assessment (OTHER), Anamorelin Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT03035409?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03035409 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fasted vs. Fed State Exercise
RECRUITING · Phase 2
-
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
RECRUITING · Phase 2
-
Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes
RECRUITING · Phase 2
-
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
RECRUITING · Phase 2
-
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus
RECRUITING · Phase 2
-
Effects of Mirtazapine on Appetite in Advanced Cancer Patients
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.